Investment Summary

Cathay Capital Private Equity Invests In Kredivo

On November 1, 2019, private equity firm Cathay Capital Private Equity invested in software company Kredivo

Investment Highlights
  • This is Cathay Capital Private Equity’s 4th transaction in the Software sector.
  • This is Cathay Capital Private Equity’s 1st transaction in Singapore.

Investment Summary

Date 2019-11-01
Target Kredivo
Sector Software
Investor(s) Cathay Capital Private Equity
Deal Type Venture

Target

Kredivo

Singapore, Singapore
Kredivo provides instant consumer credit platform credit financing for e-commerce purchases and personal loans in a "buy now and pay later” model. Kredivo is based in Singapore.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Cathay Capital Private Equity

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2006
PE ASSETS 5.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Cathay Capital Private Equity SAS is a French Chinese private equity firm focused on acquiring businesses in France, Hong Kong, and China. Cathay looks to help Western companies leverage opportunities in China and help Chinese companies leverage Western best practices and partnerships. The Firm looks to invest in businesses generating €5 to €150 million in revenues. Areas of interest include retail, consumer goods, electrical equipment, medical devices, pharmaceuticals, animal healthcare, translation, food, consumer services, and software. Cathay Capital Private Equity SAS was formed in 2007 and is based in Paris. The firm has additional offices in New York and Shanghai.


DEAL STATS #
Overall 79 of 100
Sector: Software M&A 4 of 6
Type: Venture M&A Deals 13 of 22
Country: Singapore M&A 1 of 1
Year: 2019 M&A 10 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-03 DayTwo

Walnut Creek, California, United States

DayTwo is an evidence-based, actionable, microbiome platform in the market. DayTwo leverages their first-rate scientific experience, with clinical trials in Israel and the United States, to address the large and pressing need for diabetes management and to bring food-as-medicine to global markets for people with type 2 and prediabetes. Via gut microbiome DNA analysis, DayTwo's algorithm is able to give users food recommendations for balancing their blood sugar levels. DayTwo was founded in 2015 and is based in Walnut Creek, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-02 Universal Medical Imaging

Shanghai, China

Universal Medical Imaging is a first third-party imaging center that provides customers with professional image investigation and deep physical examination service. Universal Medical Imaging was founded in 2011 and is based in Shanghai, China.

Buy -